Loading...
Aptamer-Functionalized Drug Nanocarrier Improves Hepatocellular Carcinoma toward Normal by Targeting Neoplastic Hepatocytes
Site-specific delivery of chemotherapeutics specifically to neoplastic hepatocytes without affecting normal hepatocytes should be a focus for potential therapeutic management of hepatocellular carcinoma (HCC). The aptamer TLS 9a with phosphorothioate backbone modifications (L5) has not been explored...
Na minha lista:
| Udgivet i: | Mol Ther Nucleic Acids |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Gene & Cell Therapy
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7063179/ https://ncbi.nlm.nih.gov/pubmed/32146417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtn.2020.01.034 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|